Abeona Therapeutics Inc. (ABEO) financial statements and ratios from SEC XBRL: revenue $5.82M (TTM), net margin 1223.1%, revenue growth 2745.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $5.82M |
| Net Margin | 1223.1% |
| Revenue Growth (YoY) | 2745.0% |
| EPS Growth (YoY) | -116.9% |
| FCF Growth (YoY) | -17.1% |
| Price / Book | 2.71 |
| Price / Sales | 14.36 |
| FCF Yield | -23.4% |
| Altman Z-Score | -1.63 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ABEO overview · ABEO earnings · ABEO KPIs · ABEO investor relations · ABEO ownership · ABEO peers · ABEO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.